Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Douillard · SciRah

Researcher profile · Semantic Scholar

J. Douillard

Share profile

J. Douillard — researcher profile on SciRah

h-index: 91
Works: 523
Citations: 50K

Most-cited papers

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
E. Van Cutsem, A. Cervantes, R. Adam, A. Sobrero +43 more
2016Annals of Oncology3,251 citations Open access
Semantic Scholar
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group.
F. Mosele, J. Remon, J. Mateo, C. B. Westphalen +18 more
2020Annals of Oncology1,062 citations Open access
Semantic Scholar
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
C. Luchini, F. Bibeau, M. Ligtenberg, Naveena Singh +7 more
2019Annals of Oncology933 citations Open access
Semantic Scholar
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials †
D. Arnold, B. Lueza, J. Douillard, M. Peeters +8 more
2017Annals of Oncology791 citations Open access
Semantic Scholar
ESMO-Magnitude of Clinical Benefit Scale version 1.1
N. Cherny, U. Dafni, J. Bogaerts, N. Latino +6 more
2017Annals of Oncology587 citations Open access
Semantic Scholar
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
C. Marchiò, M. Scaltriti, M. Ladanyi, A. Iafrate +8 more
2019Annals of Oncology350 citations Open access
Semantic Scholar
Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.
E. Brambilla, G. Le Teuff, S. Marguet, S. Lantuejoul +13 more
2016Journal of Clinical Oncology338 citations Open access
Semantic Scholar
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
Yi-Long Wu, D. Planchard, S. Lu, H. Sun +12 more
2019Annals of Oncology285 citations Open access
Semantic Scholar
Global cancer control: responding to the growing burden, rising costs and inequalities in access
G. Prager, Sofia Braga, B. Bystricky, C. Qvortrup +23 more
2018ESMO Open284 citations Open access
Semantic Scholar
Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)
A. Ferrari, D. Stark, F. Peccatori, L. Fern +15 more
2021ESMO Open256 citations Open access
Semantic Scholar
Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies
N. Boeckx, R. Koukakis, K. O. de Beeck, C. Rolfo +6 more
2017Annals of Oncology207 citations Open access
Semantic Scholar
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO.
L.-T. Chen, E. Martinelli, A. Cheng, G. Pentheroudakis +25 more
2020Annals of Oncology202 citations Open access
Semantic Scholar
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
A. Marabelle, R. Andtbacka, K. Harrington, I. Melero +20 more
2018Annals of Oncology197 citations Open access
Semantic Scholar
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database.
L. Renfro, F. Loupakis, R. Adams, M. Seymour +20 more
2016Journal of Clinical Oncology131 citations Open access
Semantic Scholar
JSCO/ESMO/ASCO/JSMO/TOS: International expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
T. Yoshino, G. Pentheroudakis, S. Mishima, M. Overman +15 more
2020Annals of Oncology123 citations Open access
Semantic Scholar
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research.
C. Belli, F. Penault-Llorca, M. Ladanyi, N. Normanno +12 more
2021Annals of Oncology117 citations Open access
Semantic Scholar
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project
K. Sjoquist, L. Renfro, R. Simes, Niall C. Tebbutt +29 more
2018Journal of the National Cancer Institute104 citations Open access
Semantic Scholar
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Keunchil Park, Johan Vansteenkiste, Ki Hyeong Lee, G. Pentheroudakis +19 more
2020Annals of Oncology102 citations Open access
Semantic Scholar
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy.
F. Shepherd, B. Lacas, G. Le Teuff, P. Hainaut +12 more
2017Journal of Clinical Oncology102 citations Open access
Semantic Scholar
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE‐Bio Pooled Analysis
Xiao-Li Ma, G. Le Teuff, B. Lacas, M. Tsao +12 more
2016Journal of Thoracic Oncology101 citations Open access
Semantic Scholar
Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer.
D. D. De Ruysscher, C. Faivre-Finn, K. Nackaerts, K. Jordan +4 more
2020Annals of Oncology100 citations Open access
Semantic Scholar
ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer
L. Vecchione, S. Stintzing, G. Pentheroudakis, J. Douillard +1 more
2020ESMO Open98 citations Open access
Semantic Scholar
Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score.
N. Cherny, E. D. de Vries, U. Dafni, E. Garrett-Mayer +15 more
2019Journal of Clinical Oncology95 citations Open access
Semantic Scholar
The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey
E. Saloustros, D. Stark, K. Michailidou, G. Mountzios +6 more
2017ESMO Open64 citations Open access
Semantic Scholar
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Young-Ae Park, E. Senkus-Konefka, S. Im, G. Pentheroudakis +18 more
2020Annals of Oncology63 citations Open access
Semantic Scholar
A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer.
V. Heinemann, F. Rivera, B. O'Neil, S. Stintzing +3 more
2016European Journal of Cancer63 citations Open access
Semantic Scholar
ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer
S. Catanese, G. Pentheroudakis, J. Douillard, F. Lordick
2020ESMO Open61 citations Open access
Semantic Scholar
Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients
M. Caulet, T. Lecomte, O. Bouché, J. Rollin +13 more
2016Clinical Pharmacokinetics55 citations Open access
Semantic Scholar
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
Hugues Bourgeois, F. Grudé, P. Solal-Céligny, O. Dupuis +49 more
2017Annals of Oncology49 citations Open access
Semantic Scholar
BRAFV600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database
R. Cohen, Heshan Liu, J. Fiskum, R. Adams +18 more
2021Journal of the National Cancer Institute43 citations Open access
Semantic Scholar
Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?
A. Eniu, N. Cherny, M. Bertram, S. Thongprasert +4 more
2019ESMO Open43 citations Open access
Semantic Scholar
Effect of Primary Tumor Location on Second‐ or Later‐line Treatment Outcomes in Patients With RAS Wild‐type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies
N. Boeckx, R. Koukakis, Ken Op de Beeck, C. Rolfo +6 more
2018Clinical colorectal cancer43 citations Open access
Semantic Scholar
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.
T. Aparicio, M. Ducreux, R. Faroux, E. Barbier +305 more
2018European Journal of Cancer41 citations Open access
Semantic Scholar
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database.
L. Renfro, R. Goldberg, A. Grothey, A. Sobrero +23 more
2017Journal of Clinical Oncology39 citations Open access
Semantic Scholar
The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
A. Sobrero, A. Grothey, T. Iveson, R. Labianca +10 more
2018Annals of Oncology37 citations Open access
Semantic Scholar
Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients with Elevated CEA.
Pat Gulhati, Jun Yin, L. Pederson, H. Schmoll +9 more
2020Journal of the National Cancer Institute34 citations Open access
Semantic Scholar
Panitumumab‐based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials
D. Modest, F. Rivera, J. Bachet, F. De Braud +4 more
2019International Journal of Cancer32 citations Open access
Semantic Scholar
Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study
M. Gottfried, J. Bennouna, I. Bondarenko, J. Douillard +10 more
2017Targeted oncology31 citations
Semantic Scholar
Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey
Chi-Kong Li, R. Dalvi, K. Yonemori, H. Ariffin +14 more
2019ESMO Open27 citations Open access
Semantic Scholar
Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
U. Dafni, D. Karlis, Xanthi Pedeli, J. Bogaerts +8 more
2017ESMO Open26 citations Open access
Semantic Scholar
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer.
C. Bascoul-Mollevi, S. Gourgou, M. Galais, J. Raoul +7 more
2017European Journal of Cancer25 citations
Semantic Scholar
Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial.
E. Jouglar, V. Isnardi, D. Goulon, C. Ségura-Ferlay +5 more
2017Radiotherapy and Oncology25 citations
Semantic Scholar
LACE‐Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry‐based Biomarkers in Resected Non–small‐cell Lung Cancer
L. Seymour, G. Le Teuff, E. Brambilla, F. Shepherd +16 more
2019Clinical Lung Cancer24 citations
Semantic Scholar
Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study
N. Udar, C. Lofton-Day, Jun Dong, D. Vavrek +8 more
2018Journal of Cancer Research and Clinical Oncology23 citations Open access
Semantic Scholar
ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy
J. Pérez-Gracia, A. Awada, Emiliano Calvo, T. Amaral +9 more
2020ESMO Open20 citations Open access
Semantic Scholar
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
M. Fukuoka, S. Yano, G. Giaccone, T. Tamura +16 more
2022Journal of Clinical Oncology19 citations
Semantic Scholar
A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group
H. Bleiberg, G. Decoster, A. de Gramont, P. Rougier +13 more
2017Annals of Oncology19 citations Open access
Semantic Scholar
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
G. Morgan, M. Lambertini, H. Kourie, T. Amaral +36 more
2016ESMO Open18 citations Open access
Semantic Scholar
Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial
S. Siena, J. Tabernero, G. Bodoky, D. Cunningham +7 more
2016ESMO Open18 citations Open access
Semantic Scholar
Treatment sequence of synchronously (liver) metastasized colon cancer.
T. Gruenberger, G. Beets, J. Van Laethem, P. Rougier +12 more
2016Digestive and Liver Disease17 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Tabernero×9
Invite
J. Tabernero — researcher profile on SciRah
E. Van Cutsem×7
Invite
E. Van Cutsem — researcher profile on SciRah
V. Heinemann×7
Invite
V. Heinemann — researcher profile on SciRah
G. Pentheroudakis×7
Invite
G. Pentheroudakis — researcher profile on SciRah

×7

Invite

A. de Gramont — researcher profile on SciRah

Invite

H. Schmoll — researcher profile on SciRah

B. Chibaudel×6

Invite

B. Chibaudel — researcher profile on SciRah

Invite

A. Falcone — researcher profile on SciRah

Invite

S. Jezdic — researcher profile on SciRah

A. Cervantes×5

Invite

A. Cervantes — researcher profile on SciRah

C. Zielinski×5

Invite

C. Zielinski — researcher profile on SciRah

Invite

R. Koukakis — researcher profile on SciRah